Navigation Links
Cancer Outpatients at Greater Risk for Blood Clots
Date:12/12/2011

MONDAY, Dec. 12 (HealthDay News) -- Cancer patients receiving chemotherapy most often develop blood clots after they are discharged from the hospital, according to a large new study.

Efforts to prevent this common and potentially life-threatening complication of cancer treatment should focus on outpatients -- not those still in the hospital, the researchers said.

A blood clot, also called a venous thromboembolism (VTE), is a mass of red blood cells, clotting proteins and platelets that block the flow of blood. Once cancer patients develop one clot, they're much more likely to develop others, according to a news release from the University of Rochester Medical Center.

"One in five patients develops blood clots after a cancer diagnosis and we believe that number is rising," study author Dr. Alok Khorana, an associate professor in the James P. Wilmot Cancer Center at URMC, said in the release.

After examining nearly 18,000 cancer patients over four years, the researchers found that of the 5.6 percent who developed blood clots, 78 percent were receiving treatment as outpatients.

The retrospective, observational study is slated for presentation Monday at the American Society of Hematology annual meeting in San Diego. Data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

"The Surgeon General recently issued a Call to Action to reduce VTE. At this point public health efforts have focused on inpatient prophylaxis. These new data suggest that to reduce the burden of VTE in cancer patients, prevention efforts will have to shift to the outpatient arena as well," Khorana said.

Doing so would reduce health care costs, the researchers suggested.

Cancer patients need more information on blood clots, they also said.

"Ongoing public health issues that we must address are how to educate patients on the importance of blood clot prevention, and improving compliance to preventive treatment," Khorana said. "Patients should immediately report to their physicians any unusual symptoms such as swelling or redness in limbs, or shortness of breath, even if they are otherwise feeling well."

More information

The U.S. National Cancer Institute provides more information on treatment of cancer.

-- Mary Elizabeth Dallas

SOURCE: University of Rochester Medical Center, news release, Dec. 12, 2011.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Childhood cancer survivors exposure to chemotherapy, radiation does not increase risk of birth defects in their children
2. Are Too Many Older People Screened for Cancer?
3. Scientists develop vaccine that attacks breast cancer in mice
4. Massive DNA search uncovers new mutations driving blood cancer
5. Scientists discover new way to target cancer
6. Side Effects Cause Many Older Women to Drop Breast Cancer Drugs
7. Breast cancer survivors struggle with cognitive problems several years after treatment
8. Breast cancer patients face increasing number of imaging visits before surgery
9. SABCS: Loss of RB in triple negative breast cancer associated with favorable clinical outcome
10. Why women quit breast cancer drugs early
11. Researchers identify a novel therapeutic approach for liver cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Outpatients at Greater Risk for Blood Clots
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market leader ... led by Eastside Partners, with participation from existing investor Martin Ventures. The ... accelerate its technology and product roadmap. , “Jvion is experiencing significant ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
Breaking Medicine Technology: